Dementia
Conditions
Interventions
MR imaging study with unapproved 0-17-labeled water
Sponsors
Obata Takayuki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Healthy subject aged between 18 to 39 years old at informed consent 2.Subjects who weighs 60 kg or less 3.Subjects who provide written informed consent
Exclusion criteria
Exclusion criteria: 1.Subjects with a history of illness or surgery related to the brain, eye, lumbar spine, liver, or gall bladder 2.Subjects who are ill-qualified for MRI examination 3.Subjects who are claustrophobic and nyctophobia 4.Subjects who have serious hypersensitivity to drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of O-17 MRI imaging of normal brain based on intravenous injection of O-17-labeled water | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Evaluation and analysis method of O-17 MR images of each imaging area (brain, eye, lumbar spine, liver, gall bladder) after intravenous injection of O-17-labeled water 2) Safety of intravenous injection of O-17-labeled water 3) Comparison of O-17 labeled water distribution in O-17 MRI images obtained from each imaging area | — |
Contacts
Public ContactTakayuki Obata
National Institutes for Quantum Science and Technology
Outcome results
None listed